108 related articles for article (PubMed ID: 24801586)
1. Surgical remission of Cushing's syndrome reduces cardiovascular risk.
Terzolo M; Allasino B; Pia A; Peraga G; Daffara F; Laino F; Ardito A; Termine A; Paccotti P; Berchialla P; Migliaretti G; Reimondo G
Eur J Endocrinol; 2014 Jul; 171(1):127-36. PubMed ID: 24801586
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
[TBL] [Abstract][Full Text] [Related]
4. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.
Hammer GD; Tyrrell JB; Lamborn KR; Applebury CB; Hannegan ET; Bell S; Rahl R; Lu A; Wilson CB
J Clin Endocrinol Metab; 2004 Dec; 89(12):6348-57. PubMed ID: 15579802
[TBL] [Abstract][Full Text] [Related]
5. Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up.
Ntali G; Asimakopoulou A; Siamatras T; Komninos J; Vassiliadi D; Tzanela M; Tsagarakis S; Grossman AB; Wass JA; Karavitaki N
Eur J Endocrinol; 2013 Nov; 169(5):715-23. PubMed ID: 23996696
[TBL] [Abstract][Full Text] [Related]
6. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
Pecori Giraldi F; Andrioli M; De Marinis L; Bianchi A; Giampietro A; De Martin M; Sacco E; Scacchi M; Pontecorvi A; Cavagnini F
Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
[TBL] [Abstract][Full Text] [Related]
7. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
8. Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of Cushing's syndrome.
Wagenmakers M; Roerink S; Gil L; Plantinga T; Smit J; Netea-Maier R; Hermus A
Clin Endocrinol (Oxf); 2015 Feb; 82(2):180-7. PubMed ID: 25323660
[TBL] [Abstract][Full Text] [Related]
9. Early repeat surgery for persistent Cushing's disease.
Ram Z; Nieman LK; Cutler GB; Chrousos GP; Doppman JL; Oldfield EH
J Neurosurg; 1994 Jan; 80(1):37-45. PubMed ID: 8271020
[TBL] [Abstract][Full Text] [Related]
10. Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
Dekkers OM; Horváth-Puhó E; Jørgensen JO; Cannegieter SC; Ehrenstein V; Vandenbroucke JP; Pereira AM; Sørensen HT
J Clin Endocrinol Metab; 2013 Jun; 98(6):2277-84. PubMed ID: 23533241
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group.
Bochicchio D; Losa M; Buchfelder M
J Clin Endocrinol Metab; 1995 Nov; 80(11):3114-20. PubMed ID: 7593411
[TBL] [Abstract][Full Text] [Related]
12. Adipokines and cardiovascular risk in Cushing's syndrome.
Valassi E; Biller BM; Klibanski A; Misra M
Neuroendocrinology; 2012; 95(3):187-206. PubMed ID: 22057123
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease in Cushing's syndrome: heart versus vasculature.
De Leo M; Pivonello R; Auriemma RS; Cozzolino A; Vitale P; Simeoli C; De Martino MC; Lombardi G; Colao A
Neuroendocrinology; 2010; 92 Suppl 1():50-4. PubMed ID: 20829618
[TBL] [Abstract][Full Text] [Related]
14. Repeat transsphenoidal surgery for Cushing's disease.
Friedman RB; Oldfield EH; Nieman LK; Chrousos GP; Doppman JL; Cutler GB; Loriaux DL
J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
[TBL] [Abstract][Full Text] [Related]
15. Body Composition is Different After Surgical or Pharmacological Remission of Cushing's Syndrome: A Prospective DXA Study.
Ceccato F; Boccato M; Zilio M; Barbot M; Frigo AC; Luisetto G; Boscaro M; Scaroni C; Camozzi V
Horm Metab Res; 2017 Sep; 49(9):660-666. PubMed ID: 28718178
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
[TBL] [Abstract][Full Text] [Related]
17. Effect of hypercortisolism control on high blood pressure in Cushing's syndrome.
Gómez RM; Albiger NM; Díaz AG; Moncet D; Pitoia FA; Bruno OD
Medicina (B Aires); 2007; 67(5):439-44. PubMed ID: 18051226
[TBL] [Abstract][Full Text] [Related]
18. Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile.
Dovio A; Allasino B; Palmas E; Ventura M; Pia A; Saba L; Aroasio E; Terzolo M; Angeli A
J Clin Endocrinol Metab; 2007 May; 92(5):1803-8. PubMed ID: 17327380
[TBL] [Abstract][Full Text] [Related]
19. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.
Mancini T; Kola B; Mantero F; Boscaro M; Arnaldi G
Clin Endocrinol (Oxf); 2004 Dec; 61(6):768-77. PubMed ID: 15579193
[TBL] [Abstract][Full Text] [Related]
20. Cushing`s disease: Fibrinogen and D-dimer levels fail to normalize despite early postoperative remission - a prospective, controlled study.
Witek P; Zieliński G; Szamotulska K; Witek J; Kamiński G
Endokrynol Pol; 2016; 67(3):283-91. PubMed ID: 26884303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
